Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 125

1.

3D-QSAR modeling of non-peptide antagonists for the human luteinizing hormone-releasing hormone receptor.

Tundidor-Camba A, Caballero J, Coll D.

Med Chem. 2013 Jun 1;9(4):560-70.

PMID:
23072588
2.

3D-QSAR studies of substituted 1-(3, 3-diphenylpropyl)-piperidinyl amides and ureas as CCR5 receptor antagonists.

Aher YD, Agrawal A, Bharatam PV, Garg P.

J Mol Model. 2007 Apr;13(4):519-29.

PMID:
17345108
3.

CoMFA and CoMSIA 3D QSAR analysis on N1-arylsulfonylindole compounds as 5-HT6 antagonists.

Doddareddy MR, Cho YS, Koh HY, Pae AN.

Bioorg Med Chem. 2004 Aug 1;12(15):3977-85.

PMID:
15246074
4.

3D QSAR and molecular docking studies of benzimidazole derivatives as hepatitis C virus NS5B polymerase inhibitors.

Patel PD, Patel MR, Kaushik-Basu N, Talele TT.

J Chem Inf Model. 2008 Jan;48(1):42-55.

PMID:
18076152
5.
6.

Computational Analysis of CRTh2 receptor antagonist: A Ligand-based CoMFA and CoMSIA approach.

Babu S, Sohn H, Madhavan T.

Comput Biol Chem. 2015 Jun;56:109-21. doi: 10.1016/j.compbiolchem.2015.04.007.

PMID:
25935115
8.

CoMFA and CoMSIA 3D-QSAR analysis of DMDP derivatives as anti-cancer agents.

Srivastava V, Kumar A, Mishra BN, Siddiqi MI.

Bioinformation. 2008 Jun 27;2(9):384-91.

9.

Molecular docking and 3D-QSAR studies on triazolinone and pyridazinone, non-nucleoside inhibitor of HIV-1 reverse transcriptase.

Sivan SK, Manga V.

J Mol Model. 2010 Jun;16(6):1169-78. doi: 10.1007/s00894-009-0625-8.

PMID:
20013136
10.

Molecular docking and 3D-QSAR studies of HIV-1 protease inhibitors.

Khedkar VM, Ambre PK, Verma J, Shaikh MS, Pissurlenkar RR, Coutinho EC.

J Mol Model. 2010 Jul;16(7):1251-68. doi: 10.1007/s00894-009-0636-5.

PMID:
20069323
11.
12.
13.

3D QSAR studies on T-type calcium channel blockers using CoMFA and CoMSIA.

Doddareddy MR, Jung HK, Cha JH, Cho YS, Koh HY, Chang MH, Pae AN.

Bioorg Med Chem. 2004 Apr 1;12(7):1613-21.

PMID:
15028254
14.

Design of novel quinazolinone derivatives as inhibitors for 5HT7 receptor.

Chitta A, Jatavath MB, Fatima S, Manga V.

J Recept Signal Transduct Res. 2012 Feb;32(1):3-16. doi: 10.3109/10799893.2011.610108.

PMID:
22171569
15.

Insight into the Structural Determinants of Imidazole Scaffold-Based Derivatives as TNF-α Release Inhibitors by in Silico Explorations.

Wang Y, Wu M, Ai C, Wang Y.

Int J Mol Sci. 2015 Aug 25;16(9):20118-38. doi: 10.3390/ijms160920118.

16.

Molecular docking and 3D-quantitative structure activity relationship analyses of peptidyl vinyl sulfones: Plasmodium Falciparum cysteine proteases inhibitors.

Teixeira C, Gomes JR, Couesnon T, Gomes P.

J Comput Aided Mol Des. 2011 Aug;25(8):763-75. doi: 10.1007/s10822-011-9459-4.

PMID:
21786172
17.

3D-QSAR studies on thiazolidin-4-one S1P₁receptor agonists by CoMFA and CoMSIA.

Qian C, Zheng J, Xiao G, Guo J, Yang Z, Huang L, Chao W, Rao L, Sun P.

Int J Mol Sci. 2011;12(10):6502-16. doi: 10.3390/ijms12106502.

18.
19.

CoMFA and CoMSIA studies of angiotensin (AT1) receptor antagonists.

Datar P, Desai P, Coutinho E, Iyer K.

J Mol Model. 2002 Oct;8(10):290-301. Erratum in: J Mol Model (Online). 2003 Feb;9(1):76.

PMID:
12483229
20.

Molecular docking and 3D-QSAR studies on beta-phenylalanine derivatives as dipeptidyl peptidase IV inhibitors.

Jiang YK.

J Mol Model. 2010 Jul;16(7):1239-49. doi: 10.1007/s00894-009-0637-4.

PMID:
20069322
Items per page

Supplemental Content

Support Center